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Control of Gene Expression with Small
Molecules: Biotin-Mediated Acylation of
Targeted Lysine Residues in Recombinant Yeast
protein interactions that reconstitute functional tran-
scription factors [24, 25]. This approach typically in-
volves cellular expression of two ligand binding proteins
as separate transcription factor elements. One ligand
binding protein is expressed fused to a DNA binding
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domain (DBD). The second ligand binding protein is
fused to a transcriptional activation domain (AD). Addi-
tion of the CID, which dimerizes these two proteins,Summary
recruits the transcriptional activation domain and asso-
ciated transcriptional machinery to transcriptional en-Chemical inducers of dimerization (CIDs) are powerful
hancer elements occupied by the DNA binding protein.tools for controlling diverse cellular processes. These
This interaction between two proteins, now bridged bysmall molecules typically form strong noncovalent in-
the small molecule CID, can reconstitute a functionalteractions with proteins. We report a related approach
transcription factor to activate gene expression.involving covalent acylation of a specific lysine residue
In addition to noncovalent small molecule-protein in-of a target protein by the small molecule biotin. To
teractions, the covalent modification of proteins by smallcontrol protein-protein interactions with biotin, the bi-
molecules also plays key regulatory roles in gene ex-otin protein ligase BirA from E. coli was coexpressed
pression. For example, the activation domains of manyin yeast with a streptavidin-LexA fusion protein and
transcription factors are associated with histone acyl-Avitag or BCCP biotin acceptor peptides fused to the
transferase enzymes (HATs) that covalently modify his-B42 activation domain. The addition of biotin (10 nM)
tones to enable access of proteins to DNA packed tightlyresulted in BirA-mediated biotinylation of the biotin
in chromatin [26–28]. This covalent modification involvesacceptor protein, recruitment to LexA DNA sites, and
acetylation of specific lysine residues by the endoge-maximal activation of reporter gene expression in this
nous small molecule substrate acetyl-CoA. Althoughyeast tribrid system. The high potency, low toxicity,
acylation of specific lysines by HATs is well prece-and low molecular weight of biotin as a covalent CID
dented, to our knowledge the use of exogenous agentsare attractive properties for controlling cellular pro-
to manipulate gene expression by acylating specific pro-cesses.
tein lysine residues has not been previously investi-
gated.
Introduction We report here a novel method to regulate gene ex-
pression in living yeast cells involving acylation of a
Interactions between small molecules and proteins are lysine residue with the small molecule biotin (vitamin H).
critical regulators of gene expression in eukaryotic cells. In contrast to related noncovalent CID-based systems
Representative noncovalent small molecule-protein in- for controlling gene expression, biotin was used to in-
teractions include activation or repression of transcrip- duce protein heterodimerization after covalent biotinyla-
tion controlled by ligands of members of the nuclear tion of a specific lysine residue of a target protein. Biotin
hormone receptor family of transcription factors. Bind- can be employed in this fashion because this vitamin
ing of these small molecules to their receptors triggers normally functions as a covalently linked cellular coen-
conformational changes that affect the stability of spe- zyme involved in CO2 transport [29]. Because biotin bio-cific receptor-protein complexes, thereby initiating a com- synthesis is restricted to only certain plants and fungi,
plex series of events that modulate transcription [1, 2]. many organisms, including the yeast Sacchromyces
Nature widely employs ligand-mediated protein di- cerevisiae, require external sources of biotin for optimal
merization as a mechanism to regulate gene expression growth, and these organisms possess active biotin up-
and signal transduction [3, 4]. Dimerization of transcrip- take machinery [30]. Cellular enzymes termed biotin pro-
tion factors, such as the nuclear hormone receptors tein ligases (BPLs) covalently attach biotin to proteins
by ligands, typically promotes receptor recognition of by first condensing the substrates biotin and ATP to
specific DNA sites, recruitment of components of the form biotin-AMP [31]. This BPL-bound cofactor enables
transcriptional machinery, and activation or repression nucleophilic attack by the -amine of a conserved lysine
of transcription. Related chemical inducers of protein residue on the activated carboxy group of biotin to form
dimerization (CIDs) have been developed as small mole- an amide bond [32].
cules capable of controlling and probing diverse aspects Biotinylation of lysine is a rare and highly specific
of cellular biology. CIDs have been used to investigate posttranslational modification [33]. One of the best-
signal transduction pathways [5–12], control gene ex- characterized proteins biotinylated in this way is the
pression [13–16], regulate protein secretion [17], manip- biotin carboxy carrier protein (BCCP) domain of E. coli
ulate protein splicing [18], assay enzyme activity [19, 20], acetyl CoA carboxylase [34]. This protein is biotinylated
and identify protein targets of small molecules [21–23]. in vivo by the E. coli biotin protein ligase BirA [35]. Trun-
CIDs can control gene expression by inducing protein- cation analysis of BCCP has identified a minimal 87
amino acid substrate (BCCP87) [34]. Proteins fused to
BCCP87 are biotinylated in vivo in both E. coli and S.*Correspondence: brpeters@chem.psu.edu
Chemistry & Biology
1246
Figure 1. A Molecular Illustration of BirA-
Mediated Biotinylation of a C-Terminal Avitag
Peptide
The single-letter amino acid sequence and
chemical representation of the Avitag peptide
is shown.
cerevisiae [36]. However, a much shorter 15 amino acid on solid support. Biarsinical ligands have also been used
to covalently modify specific peptide sequences in livingpeptide substrate of BirA termed Avitag has also been
identified by screening peptide libraries [37]. As shown cells [44].
in Figure 1, this short peptide undergoes efficient BirA-
mediated biotinylation of a key lysine residue, but this Results
substrate bears little sequence homology to BCCP87
[38, 39]. Biotin-Mediated Gene Expression in Yeast
Tribrid SystemsBy expressing BirA, Avitag, and streptavidin (SA) [40]
fusion proteins in yeast cells, we constructed a yeast Modifications of the yeast two-hybrid system [45]
termed “tribrid systems” have been used to detect post-tribrid system that enables protein dimerization to be
controlled by exogenously added biotin. Biotin was em- translational modification of proteins, such as tyrosine
phosphorylation [46, 47]. As illustrated schematically inployed as a cell-permeable and nontoxic small molecule
that covalently modifies a specific lysine residue of a Figure 2, we employed the interaction trap two-hybrid
approach [48] to construct a related yeast tribrid systemtarget protein. This system comprises a novel method
to manipulate reporter gene expression. Furthermore, in which reporter gene expression was designed to be
dependent on exogenous biotin. The substrate “prey”BirA-mediated biotinylation of proteins fused to the
short Avitag peptide expressed in yeast allowed isola- protein to be biotinylated comprised the bacterial B42
transcriptional activation domain fused to green fluores-tion of labeled proteins on SA (or avidin) matrices to
facilitate purification, identification, and analysis of bio- cent protein (GFP) as a spacer and fluorescent tag that
was in turn fused to a C-terminal 15 amino acid Avitagtinylated target proteins. Similar approaches for purifi-
cation of proteins from E. coli [39] and mammalian cells peptide. This protein was coexpressed in yeast with the
BirA biotin protein ligase from E. coli. The biotin binding[41] have been previously reported.
The strategy described here for affecting intracellular SA protein was also coexpressed in this system fused
to the DNA binding domain of the bacterial LexA proteininteractions is conceptually related to recent studies of
small molecule adducts of the DNA repair enzyme hAGT as the “bait” component of the tribrid assay. The LexA
DNA binding domain functions to occupy four dimeric[42, 43]. In living cells expressing hAGT fusion proteins,
this enzyme can be covalently modified on a cysteine LexA DNA sites upstream of a lacZ reporter gene. We
hypothesized that growth of these recombinant yeastresidue with small molecules linked to O6-alkylguanine
to install fluorescent tags, biotin, or immobilize proteins in media supplemented with biotin would enable BirA
Biotin-Mediated Gene Expression
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Figure 2. Schematic Representation of Biotin-Mediated Gene Expression in a Yeast Tribrid System
X-ray crystal structures of BirA (PDB 1HXD), tetrameric SA (PDB 1SWR), GFP (PDB 1EMA), and a 15 amino acid fragment of biotinylated
BCCP (PDB 1BDO) as a model of Avitag were rendered with WebLab Viewer Lite 3.2 (Molecular Simulations Inc.). The SA-Avitag complex
model was constructed by overlaying the SA-bound biotin with biotinylated lysine in an extended conformation from the Avitag model using
Macromodel 6.5 (Schro¨dinger).
to catalyze the biotinylation of the key lysine-10 residue greatest transcriptional response, enhancing gene ex-
pression by 7-fold above levels observed in the absenceof the Avitag peptide. The resulting biotinylated lysine
should bind tightly to SA on DNA, thus recruiting the of added biotin (Figure 3A). Concentrations of biotin
greater than 100 nM dramatically inhibited reporter geneB42 activation domain to DNA enhancer sites controlling
the reporter gene (Figure 2). Production of the reporter expression, presumably by saturating the biotin binding
sites of the intracellular SA proteins. Under these condi-gene product -galactosidase could be assayed with a
chromogenic substrate. tions, the lower-affinity Y43A and W120A SA mutant
proteins were significantly less effective than the high-Previous studies of SA expressed in bacteria [49] and
yeast [23] have revealed that fusion of a T7 peptide to affinity SA wt as detectors of intracellular biotinylation.
Preequilibration of the Avitag fusion substrate andthe SA N terminus facilitates efficient protein folding
in living cells. Hence, this peptide was fused to the N BirA with biotin prior to induction of expression of SA
proteins was examined as an approach to maximizeterminus of SA-LexA fusion proteins to enable functional
expression of this biotin binding protein. The high-affin- biotin-mediated gene expression. As shown in Figure
3B, this strategy increased reporter gene expressionity SA wild-type protein (biotin Kd  100 fM) [50] was
compared with the lower-affinity SA Y43A (biotin Kd  with enhancements of 10- to 20-fold observed at 10 nM
biotin. Surprisingly, the lower-affinity SA Y43A and SA100 pM) [51] and SA W120A (biotin Kd  100 nM) [52]
mutants in yeast tribrid assays. To circumvent any po- W120A mutants were similar to SA wt under these induc-
ible conditions. These results suggest that the highertential effects on growth associated with expression of
SA proteins in yeast [23], the inducible GAL1 promoter intracellular concentration of biotin likely to accumulate
in the absence of SA expression enables a greater frac-was employed to regulate protein expression [48]. In
contrast, the BirA and B42-GFP-Avitag constructs were tion of the Avitag protein to be biotinylated. This could
explain the greater overall response when SA expres-expressed constitutively from plasmids bearing the
strong ACT1 (actin) promoter [53]. This strategy allowed sion is induced. The resulting greater abundance of bio-
tinylated Avitag protein may diminish the importance ofus to compare biotin-mediated gene expression driven
by continuous expression of SA with induced expression very high-affinity interactions between SA and the target
protein. Alternatively, inducible expression of SA mayafter preequilibration of the system with biotin.
Reporter gene expression was substantially activated transiently generate a higher concentration of functional
intracellular SA, which could enhance the activity of theby the addition of biotin to yeast expressing BirA, the
Avitag fusion protein, and the SA fusion protein (Figure lower-affinity mutant proteins.
Control experiments run under conditions of inducible3). Under conditions of continuous expression of these
three protein components, addition of biotin (10 nM) to expression of SA (Figure 3C) confirmed the importance
of the three protein components and biotin in the yeastcells expressing wild-type (wt) SA protein afforded the
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Figure 4. Analysis of Biotin-Mediated Gene Expression in BCCP87-
Expressing Yeast
(A) Dose-dependent reporter gene expression with inducible ex-
pression of SA.
(B) Omission control experiments.
To compare the efficiencies of different peptide sub-
strates in yeast, the artificial 15 amino acid Avitag pep-
tide substrate was substituted with the natural E. coli-
derived 87 amino acid biotinylation substrate (BCCP87)
in the yeast tribrid system. As shown in Figure 4A, under
inducible conditions biotin potently activated dose-
dependent reporter gene expression in yeast expressing
the BCCP-derived substrate. However, the longer
BCCP87 fusion protein provided a somewhat lower
overall magnitude of response compared with the Avi-Figure 3. Analysis of Biotin-Mediated Gene Expression in Avitag-
tag-derived substrate. Alanine mutagenesis confirmedExpressing Yeast
that this activation required lysine-53 of BCCP87, which(A) Dose-dependent reporter gene expression with constitutive ex-
pression of SA. is the key residue biotinylated by BirA (Figure 4B) [38].
(B) Dose-dependent reporter gene expression with inducible ex- In contrast to the Avitag substrate, control experiments
pression of SA. revealed that BCCP87 partially activated reporter gene
(C) Omission control experiments.
expression in the absence of BirA. This result is consis-
tent with previous reports demonstrating that BCCP87
can be biotinylated by endogenous yeast biotin proteintribrid system. Moreover, site-directed mutagenesis to
ligase activity [36].alanine of the key Avitag lysine-10 (K10) residue, pre-
dicted to be biotinylated by the BirA enzyme, abolished
reporter gene expression. Under identical assay condi- Analysis of Protein Expression
and Biotinylation In Vitrotions, reporter gene expression driven by the Avitag
K10A mutant at 10 nM biotin was diminished by 1000- Immunoblotting of yeast cell extracts was employed to
verify expression of the protein components of the yeastfold compared with the unmodified Avitag fusion pro-
tein. These results provide strong evidence that reporter tribrid system. As shown in Figure 5A, expression of
these proteins was confirmed by detection of HA epi-gene expression in this tribrid system results from biotin-
mediated acylation of the Avitag K10 residue, resulting tope tags fused to the N terminus of each protein. These
experiments further confirmed that the transcriptionallyin interactions between the B42AD-GFP-Avitag and SA-
LexA fusion proteins. The partial activation observed in inactive Avitag K10A mutant was expressed at similar
levels as the functional wild-type protein. This approachthe absence of exogenous biotin indicated that BirA
transfers the limited endogenous biotin present in the also enabled estimation of the extent of biotinylation of
the Avitag substrate by BirA using a gel-shift assaybiotin-free liquid yeast media employed or contained
within intracellular stores resulting from earlier growth (10 nM biotin). This assay examined the migration in an
SDS page gel of the Avitag substrate fusion protein inon biotin-containing solid media to the Avitag substrate.
Biotin-Mediated Gene Expression
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Figure 6. Differential Interference Contrast and Epifluorescence Mi-
crographs of Streptavidin-Agarose Beads Treated with Crude Ex-
tracts from Yeast Expressing Biotinylated Avitag or K10A Mutant
Avitag Fusion Proteins
(A) Treatment with B42-GFP-Avitag extract.Figure 5. Detection of Protein Expression in Yeast Cell Extracts by
(B) Treatment of beads with biotin (2 mM) as a competitor followedImmunoblotting
by the B42-GFP-Avitag extract.
(A) Yeast expressing the following proteins were probed to detect
(C) Treatment with B42-GFP-Avitag K10A extract.
fused HA epitope tags. Lane 1: B42-GFP-Avitag, BirA, and T7SA-
LexA; lane 2: B42-GFP-Avitag K10A, BirA, T7SA-LexA; lane 3: T7SA-
LexA; lane 4: BirA; lane5: B42-GFP-Avitag. ratio in this system, it may be possible to screen libraries
(B) Gel-shift assays involving SA (12 g per lane) added to extracts of mutant BirA proteins to identify mutants that do not
of yeast expressing the biotinylated B42-GFP-Avitag or nonbiotinyl- efficiently transfer these low levels of residual biotin.
ated B42-GFP-Avitag K10A. Directed evolution might also identify BirA mutants ca-
(C) Detection of biotinylated proteins from extracts of biotin-treated
pable of transferring synthetic biotin derivatives to target(10 nM) yeast expressing BirA and Avitag or Avitag K10A fusion
substrate proteins. This approach was recently used toproteins. The blot was probed with SA-alkaline phosphatase.
optimize the enzyme hAGT to improve covalent labeling(D) Analysis of residual biotinylation in cells expressing BirA and
Avitag fusion proteins. Extracts of untreated and biotin-treated cells of a fused protein tag with small molecule substrates [54].
were probed with SA-alkaline phosphatase. To examine the possibility of isolating biotinylated
Avitag fusion proteins with an affinity matrix, extracts of
yeast expressing BirA and B42-GFP-Avitag and treated
the presence or absence of excess purified SA protein with biotin (8 nM) were added to streptavidin-agarose
added to cell extracts. This gel-shift assay revealed that beads. As shown in Figure 6, epifluorescence micros-
all of the B42-GFP-Avitag protein isolated from BirA- copy of these beads revealed bright green fluorescence
expressing biotin-treated yeast formed a higher-molec- corresponding to immobilized GFP-Avitag fusion pro-
ular weight complex with SA (Figure 5B). Control ex- tein. This interaction was specific as evidenced by the
periments showed that added SA did not affect the absence of green fluorescence upon competition with
analogous Avitag K10A mutant under identical condi- excess biotin. Furthermore, analogous extracts of yeast
tions. These results demonstrated that the Avitag sub- expressing the B42-GFP-Avitag K10A mutant protein
strate is completely biotinylated by BirA under these did not confer bead-associated green fluorescence,
conditions. In addition, exclusive biotinylation of the Avi- confirming the importance of the biotinylated K10 resi-
tag fusion protein but not the K10A mutant protein was due (Figure 6). These results indicate that biotinylated
detected by probing nitrocellulose-immobilized protein Avitag fusion proteins expressed in yeast can be readily
with SA conjugated to alkaline phosphatase (Figure 5C). isolated using SA (or avidin) proteins immobilized on a
These in vitro results demonstrated the high specificity solid support. This approach may be useful for isolation
of BirA-mediated biotinylation of the Avitag substrate. of recombinant proteins requiring eukaryotic posttrans-
Furthermore, by comparing biotinylation in the presence lational modifications from crude yeast extracts.
and absence of added biotin, the extent of background
biotinylation of Avitag was determined to be ca. 20% Discussion
(Figure 5D). This result is consistent with the level of
background transcriptional activity observed in the ab- Small molecules that dimerize proteins in cells are pow-
erful tools for controlling diverse biological processes.sence of added biotin. To improve the signal-to-noise
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Typical CIDs function by forming strong noncovalent Competition by free biotin would block access to DNA of
the B42 activation domain fused to the Avitag substrate.interactions with target proteins. As an alternative, we
report here the covalent acylation of specific lysine resi- Similar but less effective autoinhibition has been pre-
viously observed in yeast three-hybrid systems regu-dues by the small molecule biotin. This strategy provides
a novel approach for regulating gene expression. In ad- lated by high-affinity noncovalent chemical inducers of
dimerization [23].dition, in contrast to most noncovalent small molecule-
protein interactions, the covalent modification of pro- The minimalist artificial Avitag substrate was com-
pared with the natural 87 amino acid BCCP substrateteins by small molecules has the potential to enable
pulse-chase experiments that allow tracking of proteins from E. coli. These experiments revealed that Avitag
engenders higher levels of biotin-mediated gene ex-as a function of time.
Construction of a yeast tribrid system enabled biotin pression than its natural counterpart. Furthermore, con-
sistent with previous reports [36], the BCCP87 substrateto function as an activator or inhibitor of gene expression
dependent on the concentration of this small molecule. was at least partially biotinylated by endogenous yeast
biotin protein ligase. In contrast, Avitag was biotinylatedThis system employed yeast engineered to coexpress
the E. coli biotin protein ligase BirA, a SA-LexA DNA exclusively by the BirA enzyme.
We demonstrate that biotin can be employed as abinding domain fusion protein, and the Avitag peptide
substrate fused to the B42 activation domain. Treatment highly potent small molecule regulator of gene expres-
sion in recombinant yeast. This high potency deriveswith biotin allowed the BirA enzyme to catalyze the intra-
cellular formation of biotin-AMP [55] and execute highly in part from the efficient uptake and rapid intracellular
accumulation of biotin. The availability of high concen-specific biotinylation of the lysine-10 residue of the Avi-
tag substrate [38]. This precise protein modification al- trations of cytoplasmic biotin enables rapid and highly
specific covalent biotinylation of the key lysine-10 resi-lowed capture of the fused B42 activation domain by
the DNA-tethered SA protein. This DNA-bound protein due of the Avitag substrate protein by BirA. The high
efficiency and specificity of this process suggests thatwas positioned to control activation of a lacZ reporter
gene. BirA or related mutants screened against this yeast tri-
brid system might enable transfer of synthetic deriva-Biotin proved to be a highly potent activator of gene
expression in this yeast tribrid system. Addition of 10 tives of biotin to Avitag peptides. This approach has
potential for highly specific labeling of proteins with mo-nM biotin to yeast media conferred maximal levels of
reporter gene activity. Remarkably, this concentration lecular probes appropriately linked to biotin. Addition-
ally, the facile isolation of site specifically biotinylatedis substantially below the Michaelis constant (Km) and
Kd for binding of biotin to E. coli-expressed BirA (Km, target proteins on SA or avidin affinity matrices may be
useful for purification of recombinant proteins requiring300 nM; Kcat, 0.3 s1; Kd BIOTIN, 45 nM) [56–58]. Because
S. cerevisiae sequesters free biotin, enhancing the intra- eukaryotic patterns of posttranslational modification.
Given the importance of noncovalent interactions be-cellular concentration by as many as three orders of
magnitude above the concentration in growth medium tween CIDs and target proteins for regulation of diverse
cellular processes, intracellular biotinylation may pro-[30], the high potency of biotin presumably relates in
part to the high efficiency of biotin uptake by yeast. In vide an effective covalent alternative.
addition, the use of tetrameric SA as the DNA-bound
LexA fusion protein is likely to have significantly pro-
Significancemoted biotin-mediated activation of gene expression.
Each tetrameric SA protein could potentially capture
Small molecules that control protein dimerization inup to four biotinylated activation domains to improve
living cells provide powerful probes of cellular biology.recruitment of the transcriptional machinery to enhancer
We demonstrate here that the vitamin biotin can con-sites controlling the reporter gene. Although this ap-
trol protein dimerization after covalently acylating aproach is likely to work well with monomeric biotinylated
specific lysine residue of a target protein expressedproteins, the tetrameric nature of the SA protein may
in yeast. This covalent modification of an activationcomplicate or prevent the capture of some oligomeric
domain fused to an Avitag peptide substrate, mediatedproteins.
by the biotin protein ligase BirA, potently activatedExogenous biotin mediated highly specific activation
gene expression in recombinant yeast expressing aof gene expression by enabling biotinylation of only the
DNA-bound streptavidin protein. Biotin maximally ac-lysine-10 residue of the Avitag substrate. This specific
tivated gene expression at a concentration of 10 nM,modification was confirmed by mutagenesis of this ly-
and this high potency relates in part to the efficientsine residue to alanine, which reduced biotin-mediated
intracellular accumulation of this vitamin from the ex-gene expression by 1000-fold to basal levels of reporter
tracellular environment. The BirA-mediated transfer ofgene activity. Moreover, although both the Avitag fusion
biotin to the 15 amino acid Avitag substrate was highlyprotein and the K10A mutant were expressed at similar
specific; modification of only the key lysine-10 residuelevels in yeast, only the functional Avitag fusion protein
was observed. In contrast to most noncovalent smallwas observed as the major biotinylated species present
molecule-protein interactions, covalent modificationin yeast cell extracts.
by small molecules has the potential to enable pulse-Biotin dramatically inhibited reporter gene expression
chase experiments that allow proteins to be trackedat concentrations of 100 nM or higher. This is predicted
as a function of time. This approach also provides ato result from the binding of the actively accumulated
free biotin to unoccupied biotin binding sites of SA. novel platform for the control of numerous cellular
Biotin-Mediated Gene Expression
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TGCC-3; 3SalI-Avitag-Lys10Ala: 5-ACTCCGGTCGACTTATTCGTprocesses and may enable the identification of biotin
GCCATTCGATAGCCTGAGCCTCGAAGAT-3; 5EcoRI-BCCP87: 5-analogs capable of highly specific covalent labeling of
ACTGAATTCGGTCTCGAGGGTGGTGGTATGGAAGCGCCAGCAproteins fused to the short Avitag peptide substrate.
GCA-3; 3SalI-Stop-BCCP87: 5-ACTGTCGACTTACTCGATGACGA
CCAGCGG-3; 5BCCP-K53A: 5-GTTGAAGCCATGGCTATGATGAA
Experimental Procedures CCAG-3.
General Microtiterplate -Galactosidase Reporter Gene Assays
Standard protocols were employed for microbiological techniques S. cerevisiae FY250 was transformed by the lithium acetate method
and plasmid construction [59]. Sacchromyces cerevisiae FY250 [65] with reporter gene pSH18-34 and plasmids encoding BirA, B42-
(MAT, ura3–52, his 3200, leu21, trp163), a generous gift from GFP-Avitag, and T7SA-LexA. Yeast transformants derived from mul-
Prof. M. Ptashne (Memorial Sloan Kettering), was used for cellular tiple combined colonies were grown overnight at 30C in selection
assays. Escherichia coli DH5- (Clontech) was employed for plasmid media comprising Brent supplement mixture (UraHisTrpLeu,
construction. Oligonucleotides were from IDT Technologies Inc. Mi- 1.144g/L, Qbiogene), yeast nitrogen base lacking both amino acids
crotiterplate absorbance measurements utilized a Perkin Elmer and biotin (6.7 g/L, Qbiogene), raffinose (1%, Qbiogene), and penicil-
HTS-7000 instrument. lin/streptomycin (100 /mL, Gibco). Biotin (Sigma) was added to the
media in DMSO (final DMSO conc, 1%). For the inducible experi-
Plasmid Construction ments, aliquots of saturated (16 hr) cultures (OD590, 0.7) were resus-
Genes were constructed using the polymerase chain reaction (PCR) pended in biotin-free selection media (100 L) containing raffinose
with either Pfu polymerase (Stratagene) or platinum Taq polymerase (1%), galactose (2%, Qbiogene), and penicillin-streptomycin (100
(Gibco). Genes encoding the C-terminal Avitag peptide were ampli- u/mL) for 3 hr at 30C to induce SA expression. The constitutive
fied using a modified GFPuv gene [47] as the template and 3-Avitag expression experiments employed analogous yeast cultures grown
or 3-Avitag K10A primers to append the peptide sequence in the presence of raffinose (1%) and galactose (2%) for 16 hr.
GGGLNDIFEAQKIEWHE [38] to the GFPuv C terminus. The biotinyl- The plate was centrifuged (4300 rpm, 10 min) and the supernatant
ated K10 residue is shown in bold, and the two underlined glycine removed by aspiration. Z lysis buffer (Z buffer [59] containing EtOH
residues were incorporated as a spacer at the N terminus of the [2%], CHCl3 [1%], 100 l) was added to the cell pellet and the plate
Avitag peptide. The 87 amino acid BCCP-derived biotinylation sub- was shaken for 5 min. Aliquots (20 l) of suspended cells were
strate was amplified by PCR from a thermal (95C, 5 min) lysate of transferred to wells containing Z lysis buffer (130 l) to afford the
E. coli. PCR megaprimer mutagenesis [60] was used to introduce the final volume of 150 l. The absorbance at 570 nm (OD570cells) was
BCCP87 Lys53Ala mutation. The GFPuv-Avitag and GFPuv-BCCP87 measured to determine the cell density followed by the addition of
genes were expressed from plasmid pDCWA B42, a yeast shuttle 30 l of chlorophenol red--galactopyranoside (Calbiochem, 15 mM
vector that fuses the bacterial B42 activation domain to the N termi- in 0.1 M sodium phosphate buffer, pH 7.5). The plate was shaken
nus of GFPuv-Avitag. The pDCWA expression vector is a derivative at 23C followed by absorbance measurements at 570 nm (OD570)
of pRF4-6 (a vector related to pJG4-5 [48] bearing a TRP1 selection over a period of 4 to 60 min (in 2 to 20 min intervals depending on
marker and 2  origin but lacks the B42 activation domain and SV40 the activity level). -galactosidase activity was calculated as fol-
NLS) modified by D. Clark to substitute the inducible GAL1 promoter lows: activity 	 1000 
 (OD570  OD570cells  Blank1)/(Time 

with the constitutive ACT1 (663 to 4) promoter [53] from pJP190 (OD570cells  Blank2)). The Blank1 value represents the absorbance
(a gift of Prof. M. Ptashne). Genes encoding the T7-streptavidin at 570 nm of chlorophenol-red--galactopyranoside alone (30 l).
(T7SA, 14–159) wild-type, Y43A, and W120A proteins were pre- The Blank2 value corresponds to the absorbance at 570 nm of
viously reported [23]. A 5-MfeI-T7SA-EcoRI-XhoI-3 cassette was Z lysis buffer (150 l). The time value was expressed in minutes.
cloned into MfeI/XhoI-cut pDC1 (a derivative of pLM [61] modified -galactosidase activity values represent the mean of three inde-
by D. Clark to include the following in-frame amino acids, unique pendent experiments. Error bars represent standard errors of the
in-frame restriction sites, and in-frame stop codons downstream mean. Omission control experiments employed yeast transformed
of the T7 promoter: XbaI-MRGSHHHHHHPGSRIPMA-KpnI-MfeI- with corresponding unmodified expression vectors.
EcoRI-STOP-XhoI-STOP-SalI-STOP-HindIII) to afford pDC1 T7SA
vectors. A second DNA cassette comprising MfeI-HA tag-SV40NLS- Immunoblotting
LexA-XhoI was ligated to EcoRI/XhoI-cut pDC1 T7-SA vectors to Yeast transformants from multiple combined colonies were grown
afford pDC1 MfeI-T7SA-HA tag-SV40NLS-LexA-Stop-SalI. This in- to saturation (16 hr) in appropriate selection media containing biotin
sert was isolated by digestion with MfeI/SalI and ligated to EcoRI/ (8 nM), raffinose (1%), and penicillin/streptomycin (100 u/mL). Strep-
XhoI-cut pPA1 (a variant of pBC103 [62], containing an inducible tavidin expression was induced by the addition of galactose (2%)
GAL1 promoter, LEU2 selection marker, and 2  origin, but modified for 3 hr. Cells were harvested by centrifugation (4300 rpm, 10 min),
by P. Andrade to replace the ATG-HA tag-SV40NLS with EcoRI- resuspended in one volume of 2X SDS loading buffer (125 mM Tris,
XhoI restriction sites). The gene encoding BirA (GENBANK# pH 6.8, 4% SDS, 300 mM -mercaptoethanol), frozen at –80C for
NP_418404) [63] was amplified by PCR from E. coli and flanked with 10 min, and the tubes were boiled in water for 10 min. Cell debris
in-frame 5EcoRI and 3SalI restriction sites. This gene was ligated was removed by centrifugation (8000 rpm, 5 min), and the superna-
to EcoRI/SalI cut pSM1, a derivative of pLM [61] modified by S. tant was analyzed by SDS-PAGE (Tris-glycine 15%, CAMBREX).
Martin to add a hemagglutinin (HA) epitope tag (MfeI-MASYPYDVP Proteins were transferred to nitrocellulose (PALL Life Sciences) us-
DYASP-EcoRI-XhoI-SalI) to fused proteins. The MfeI-HA tag-BirA- ing a semi-dry immunoblotting apparatus (Hoefer). The membrane
XhoI fragment was ligated to EcoRI/XhoI-cut pDCHA (a derivative was blocked using bovine serum albumin (2%, Sigma) in TBST (20
of pAM423 [64] bearing the HIS3 selection marker and 2  origin mM Tris, 150 mM NaCl, pH 7.5, 0.05% Tween-20) followed by incu-
but modified by D. Clark to replace the GAL1 promoter with the bation with mouse anti-HA antibody (Sigma, 4l in 20 ml final volume
constitutive ACT1 promoter). Plasmid pSH18-34 (Invitrogen), con- TBST). Goat-anti-mouse-alkaline phosphate conjugate (Zymed Lab-
taining the lacZ gene under the control of four dimeric LexA binding oratories Inc., 10 l in 20 ml final volume) was used as the secondary
sites, was used as the reporter. All the new constructs were con- antibody. Proteins were visualized with Western blue stabilized alka-
firmed by automated dideoxynucleotide sequencing at the Pennsyl- line phosphatase substrate (Promega). Alternatively, biotinylated
vania State University Biotechnology Institute. proteins were detected using a streptavidin-alkaline phosphatase
conjugate (Sigma, 7.5 l in 15 ml final volume) as the probe. To
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TCTGCACTACGCAGGGA-3; 3SalI-Stop-Avitag-GG-XhoI-GFP: 5- (10 nM), raffinose (1%), and penicillin/streptomycin (100 u/mL). Cell
extracts were prepared as previously described but were resus-ACTCCGGTCGACTTATTCGTGCCATTCGATTTTCTGAGCCTCGAA
GATGTCGTTCAGACCGCCACCCTCGAGTTTGTAGAGCTCATCCA pended in one volume of “lite” 2X SDS loading buffer (containing
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